Furthermore, Panther pathway analysis revealed that in breast and lung cancers, ETS2 may positively influence T-cell activation as well as the epidermal growth factor (EGF) receptor, integrin, platelet-derived growth factor (PDGF), interferon-γ (IFN-γ), p53, and cadherin signaling pathways. The gene discussed is TP53; the disease is lung carcinoma.